Arthritis Awareness & Lyme Disease

Knee osteoarthritis presents a multitude of challenges for those affected, such as reduced mobility and loss of quality of life, but the primary symptoms are pain and discomfort. Ask your doctor about ZILRETTA, the first and only FDA-approved treatment for osteoarthritis knee pain that uses extended-release microsphere technology designed to offer an extended-release corticosteroid.

Each year, some 300,000 people in the United States contract Lyme disease. Early detection and treatment are key. Now there’s a new rapid test that can change the game.

AH0087_1080P